Hfm Investment Advisors, LLC Bridge Bio Pharma, Inc. Transaction History
Hfm Investment Advisors, LLC
- $206 Billion
- Q1 2025
A detailed history of Hfm Investment Advisors, LLC transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Hfm Investment Advisors, LLC holds 3 shares of BBIO stock, worth $101. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3Holding current value
$101% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding BBIO
# of Institutions
361Shares Held
185MCall Options Held
12.8MPut Options Held
2.09M-
Viking Global Investors LP22.1MShares$744 Million2.55% of portfolio
-
Kohlberg Kravis Roberts & Co. L.P. New York, NY19.3MShares$650 Million30.7% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.9MShares$503 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$420 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X07.17MShares$242 Million0.14% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $5B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...